114 related articles for article (PubMed ID: 9766623)
1. Leukocyte trafficking in experimental autoimmune uveitis in vivo.
Parnaby-Price A; Stanford MR; Biggerstaff J; Howe L; Whiston RA; Marshall J; Wallace GR
J Leukoc Biol; 1998 Oct; 64(4):434-40. PubMed ID: 9766623
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural pathology of experimental autoimmune uveitis. Quantitative evidence of activation and possible high endothelial venule-like changes in retinal vascular endothelium.
McMenamin PG; Forrester JV; Steptoe RJ; Dua HS
Lab Invest; 1992 Jul; 67(1):42-55. PubMed ID: 1625447
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules.
Xu H; Forrester JV; Liversidge J; Crane IJ
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):226-34. PubMed ID: 12506079
[TBL] [Abstract][Full Text] [Related]
4. Reduction in shear stress, activation of the endothelium, and leukocyte priming are all required for leukocyte passage across the blood--retina barrier.
Xu H; Manivannan A; Goatman KA; Jiang HR; Liversidge J; Sharp PF; Forrester JV; Crane IJ
J Leukoc Biol; 2004 Feb; 75(2):224-32. PubMed ID: 14634055
[TBL] [Abstract][Full Text] [Related]
5. Retinal leukocyte behavior in experimental autoimmune uveoretinitis of rats.
Hamada M; Ogura Y; Miyamoto K; Nishiwaki H; Hiroshiba N; Honda Y
Exp Eye Res; 1997 Sep; 65(3):445-50. PubMed ID: 9299181
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of IFN-gamma-producing (Th1-like) cells into the inflamed retina in vivo is preferentially regulated by P-selectin glycoprotein ligand 1:P/E-selectin interactions.
Xu H; Manivannan A; Jiang HR; Liversidge J; Sharp PF; Forrester JV; Crane IJ
J Immunol; 2004 Mar; 172(5):3215-24. PubMed ID: 14978129
[TBL] [Abstract][Full Text] [Related]
7. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage.
Greenwood J; Howes R; Lightman S
Lab Invest; 1994 Jan; 70(1):39-52. PubMed ID: 8302017
[TBL] [Abstract][Full Text] [Related]
8. Effects of mycophenolate mofetil on nasal mucosal tolerance induction.
Dick AD; Kreutzer B; Laliotou B; Forrester JV
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):835-40. PubMed ID: 9538893
[TBL] [Abstract][Full Text] [Related]
9. Macrophage depletion prevents leukocyte adhesion and disease induction in experimental melanin-protein induced uveitis.
Baatz H; Puchta J; Reszka R; Pleyer U
Exp Eye Res; 2001 Jul; 73(1):101-9. PubMed ID: 11428867
[TBL] [Abstract][Full Text] [Related]
10. Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo.
Koizumi K; Poulaki V; Doehmen S; Welsandt G; Radetzky S; Lappas A; Kociok N; Kirchhof B; Joussen AM
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2184-91. PubMed ID: 12714660
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CD44 in leukocyte trafficking at the blood-retinal barrier.
Xu H; Manivannan A; Liversidge J; Sharp PF; Forrester JV; Crane IJ
J Leukoc Biol; 2002 Dec; 72(6):1133-41. PubMed ID: 12488494
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
Dick AD; McMenamin PG; Körner H; Scallon BJ; Ghrayeb J; Forrester JV; Sedgwick JD
Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162
[TBL] [Abstract][Full Text] [Related]
13. ICAM-1 and VCAM-1 are differentially expressed on blood-retinal barrier cells during experimental autoimmune uveitis.
Dewispelaere R; Lipski D; Foucart V; Bruyns C; Frère A; Caspers L; Willermain F
Exp Eye Res; 2015 Aug; 137():94-102. PubMed ID: 26093277
[TBL] [Abstract][Full Text] [Related]
14. Effect of anti-macrophage inflammatory protein-1alpha on leukocyte trafficking and disease progression in experimental autoimmune uveoretinitis.
Crane IJ; Xu H; Manivannan A; McKillop-Smith S; Lamont G; Wallace C; Liversidge J; Sharp PF; Forrester JV
Eur J Immunol; 2003 Feb; 33(2):402-10. PubMed ID: 12645937
[TBL] [Abstract][Full Text] [Related]
15. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats.
Egwuagu CE; Sztein J; Mahdi RM; Li W; Chao-Chan C; Smith JA; Charukamnoetkanok P; Chepelinsky AB
J Immunol; 1999 Jan; 162(1):510-7. PubMed ID: 9886427
[TBL] [Abstract][Full Text] [Related]
17. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis.
Butler TL; McMenamin PG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2195-210. PubMed ID: 8843906
[TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory role of ocular macrophages: the macrophages produce RANTES to suppress experimental autoimmune uveitis.
Sonoda KH; Sasa Y; Qiao H; Tsutsumi C; Hisatomi T; Komiyama S; Kubota T; Sakamoto T; Kawano Y; Ishibashi T
J Immunol; 2003 Sep; 171(5):2652-9. PubMed ID: 12928419
[TBL] [Abstract][Full Text] [Related]
19. Development of experimental autoimmune uveitis: efficient recruitment of monocytes is independent of CCR2.
Dagkalis A; Wallace C; Xu H; Liebau S; Manivannan A; Stone MA; Mack M; Liversidge J; Crane IJ
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4288-94. PubMed ID: 19357362
[TBL] [Abstract][Full Text] [Related]
20. In vivo quantification of leukocyte behavior in the retina during endotoxin-induced uveitis.
Miyamoto K; Ogura Y; Hamada M; Nishiwaki H; Hiroshiba N; Honda Y
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2708-15. PubMed ID: 8977486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
